Scientists
The following scientists are principal investigators of the CRC TRR 221 during the second period of funding (2022-2025).”
The following scientists are principal investigators of the CRC TRR 221 during the second period of funding (2022-2025).”
Within the Collaborative Research Centre/Transregio (CRC/TRR) 221 innovative immune modulation strategies will be investigated to separate GvHD from GvL effects in order to enhance the safety and efficacy of allo-HSCT in the future.